Hemab Therapeutics
PrivateLast Round
Series C
Oct 27, 2025
Total Funding Raised
$157M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
-
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Non-AI
Keywords
bleeding disorder treatmentbispecific antibodyprophylactic therapeuticsclinical-stage biotechblood disordershematologythrombotic disorder treatmenthemostasisGlanzmann Thrombastheniaantibody therapyHemophilia A/Borphan drugFVIIarare pediatric diseaseVon Willebrand Disease
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemab Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Hemab Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 27, 2025 |
Hemab Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maj Invest Equity A/S | Series C |
| RA Capital Management | Series C |
| Avoro Ventures | Series C |
| Avoro Capital | Series C |
| Deep Track Capital | Series C |
| HealthCap | Series C |
| Novo Holdings | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2025
$157M round raised.
Hemab Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hemab Therapeutics's valuation, stock price, and market status.